Filana Therapeutics, Inc. (FLNA)
NASDAQ: FLNA · Real-Time Price · USD
1.450
-0.110 (-7.05%)
Apr 29, 2026, 3:07 PM EDT - Market open
Filana Therapeutics Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Net Income | -90.97 | -24.34 | -97.22 | -76.25 | -32.39 | |
| Depreciation & Amortization | 0.94 | 1.13 | 1.53 | 1.3 | 0.53 | |
| Stock-Based Compensation | 19.58 | 16.29 | 4.59 | 2.07 | 1.76 | |
| Other Operating Activities | - | -108.18 | - | - | - | |
| Change in Accounts Payable | 33.99 | -2.92 | 6.9 | -3.45 | 6.22 | |
| Change in Other Net Operating Assets | 4.21 | 1.09 | 2.18 | -1.19 | -6.32 | |
| Operating Cash Flow | -32.25 | -116.93 | -82.03 | -77.51 | -30.2 | |
| Capital Expenditures | -0.58 | -0.1 | -0.41 | -2.71 | -22.21 | |
| Investing Cash Flow | -0.58 | -0.1 | -0.41 | -2.71 | -22.21 | |
| Issuance of Common Stock | 0.09 | 124.47 | 2.56 | 47.8 | 192.34 | |
| Other Financing Activities | -0.33 | - | - | - | - | |
| Financing Cash Flow | -0.24 | 124.47 | 2.56 | 47.8 | 192.34 | |
| Net Cash Flow | -33.07 | 7.44 | -79.88 | -32.42 | 139.93 | |
| Free Cash Flow | -32.83 | -117.03 | -82.44 | -80.23 | -52.41 | |
| Free Cash Flow Per Share | -0.68 | -2.51 | -1.97 | -2.00 | -1.33 | |
| Levered Free Cash Flow | 20.22 | -79.18 | -51.63 | -54 | -40.39 | |
| Unlevered Free Cash Flow | 20.22 | -79.18 | -51.63 | -54 | -40.39 | |
| Change in Working Capital | 38.2 | -1.83 | 9.08 | -4.64 | -0.1 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.